Paul J Weidle
Biographic Data
| ID | 6062502 |
|---|---|
| NAME | Paul J Weidle |
| GIVEN NAMES | Paul J |
| FAMILY NAME | Weidle |
| SIGNATURE | WEIDLE P J |
| AFFILIATIONS | Centers for Disease Control and Prevention |
| VERIFIED | No |
| TOTAL WORKS | 10 |
| TOTAL CITATIONS | 0 |
| WORKS AS AUTHOR | 10 |
| WORKS AS EDITOR | 0 |
| FIRST PUBLICATION YEAR | 2010 |
| LATEST PUBLICATION YEAR | 2023 |
| H-INDEX | 0 |
The Future of Pharmacist-Delivered Status-Neutral HIV Prevention and Care
The Future of Pharmacist-Delivered Status-Neutral HIV Prevention and Care Paul J. Weidle PharmD, MPH, John T. Brooks MD, Sheila Salvant Valentine JD, and Demetre Daskalakis MD, MPH Affiliation Paul J. Weidle, John T. Brooks, Sheila Salvant-Valentine, and Demetre Daskalakis are with the Division of HIV Prevention, National Center for HIV, Viral Hepatitis, STD & TB Prevention, Centers for Disease Control and Prevention (CDC), Atlanta, GA. Note. The…
Evaluation of Public Health Contact Tracing for Mpox Among Gay, Bisexual, and Other Men Who Have Sex With Men—10 US Jurisdictions, May 17–July 31, 2022
Objectives. To examine the potential impact of contact tracing to identify contacts and prevent mpox transmission among gay, bisexual, and other men who have sex with men (MSM) as the outbreak expanded. Methods. We assessed contact tracing outcomes from 10 US jurisdictions before and after access to the mpox vaccine was expanded from postexposure prophylaxis for persons with known exposure to include persons at high risk for acquisition (May 17–J…
Improvements in Retention in Care and HIV Viral Suppression Among Persons with HIV and Comorbid Mental Health Conditions
Antiretroviral Adherence Level Necessary for HIV Viral Suppression Using Real-World Data
BACKGROUND: A benchmark of near-perfect adherence (≥95%) to antiretroviral therapy (ART) is often cited as necessary for HIV viral suppression. However, given newer, more effective ART medications, the threshold for viral suppression may be lower. We estimated the minimum ART adherence level necessary to achieve viral suppression. SETTINGS: The Patient-centered HIV Care Model demonstration project. METHODS: Adherence to ART was calculated using t…
Changes in Reported Injection Behaviors Following the Public Health Response to an HIV Outbreak Among People Who Inject Drugs
Antiretroviral treatment among commercially insured persons living with HIV in an era of universal treatment in the United States – 2012–2014
In 2012, antiretroviral (ARV) treatment guidelines expanded indications and recommended antiretroviral treatment for all HIV-infected persons in the United States, regardless of CD4 cell count. This analysis describes ARV prescriptions among commercially insured HIV-infected adults from 2012 to 2014. We analyzed persons aged 18-64 years from 2012 to 2014 Truven Health MarketScan Commercial Claims and Encounters® database. We identified HIV-infect…
Factors associated with obtaining sterile syringes from pharmacies among persons who inject drugs in 20 US cities
HIV Infection Linked to Injection Use of Oxymorphone in Indiana, 2014–2015
BACKGROUND: In January 2015, a total of 11 new diagnoses of human immunodeficiency virus (HIV) infection were reported in a small community in Indiana. We investigated the extent and cause of the outbreak and implemented control measures. METHODS: We identified an outbreak-related case as laboratory-confirmed HIV infection newly diagnosed after October 1, 2014, in a person who either resided in Scott County, Indiana, or was named by another case …
How late is too late? Timeliness to scheduled visits as an antiretroviral therapy adherence measure in Nairobi, Kenya and Lusaka, Zambia
Collecting self-reported data on adherence to highly active antiretroviral therapy (HAART) can be complicated by patients' reluctance to report poor adherence. The timeliness with which patients attend visits might be a useful alternative to estimate medication adherence. Among Kenyan and Zambian women receiving twice daily HAART, we examined the relationship between self-reported pill taking and timeliness attending scheduled visits. We analyzed…
HIV Testing and HIV/Aids Treatment Services in Rural Counties in 10 Southern States
CONTEXT: Forty percent of AIDS cases are reported in the southern United States, the region with the largest proportion of HIV/AIDS cases from rural areas. Data are limited regarding provider perspectives of the accessibility and availability of HIV testing and treatment services in southern rural counties. PURPOSE: We surveyed providers in the rural south to better understand: (1) the accessibility and availability, and (2) the facilitators and …
No prominent works on this page.
How late is too late? Timeliness to scheduled visits as an antiretroviral therapy adherence measure in Nairobi, Kenya and Lusaka, Zambia
Collecting self-reported data on adherence to highly active antiretroviral therapy (HAART) can be complicated by patients' reluctance to report poor adherence. The timeliness with which patients attend visits might be a useful alternative to estimate medication adherence. Among Kenyan and Zambian women receiving twice daily HAART, we examined the relationship between self-reported pill taking and timeliness attending scheduled visits. We analyzed…
HIV Testing and HIV/Aids Treatment Services in Rural Counties in 10 Southern States
CONTEXT: Forty percent of AIDS cases are reported in the southern United States, the region with the largest proportion of HIV/AIDS cases from rural areas. Data are limited regarding provider perspectives of the accessibility and availability of HIV testing and treatment services in southern rural counties. PURPOSE: We surveyed providers in the rural south to better understand: (1) the accessibility and availability, and (2) the facilitators and …
HIV Infection Linked to Injection Use of Oxymorphone in Indiana, 2014–2015
BACKGROUND: In January 2015, a total of 11 new diagnoses of human immunodeficiency virus (HIV) infection were reported in a small community in Indiana. We investigated the extent and cause of the outbreak and implemented control measures. METHODS: We identified an outbreak-related case as laboratory-confirmed HIV infection newly diagnosed after October 1, 2014, in a person who either resided in Scott County, Indiana, or was named by another case …
Antiretroviral treatment among commercially insured persons living with HIV in an era of universal treatment in the United States – 2012–2014
In 2012, antiretroviral (ARV) treatment guidelines expanded indications and recommended antiretroviral treatment for all HIV-infected persons in the United States, regardless of CD4 cell count. This analysis describes ARV prescriptions among commercially insured HIV-infected adults from 2012 to 2014. We analyzed persons aged 18-64 years from 2012 to 2014 Truven Health MarketScan Commercial Claims and Encounters® database. We identified HIV-infect…
Factors associated with obtaining sterile syringes from pharmacies among persons who inject drugs in 20 US cities
Antiretroviral Adherence Level Necessary for HIV Viral Suppression Using Real-World Data
BACKGROUND: A benchmark of near-perfect adherence (≥95%) to antiretroviral therapy (ART) is often cited as necessary for HIV viral suppression. However, given newer, more effective ART medications, the threshold for viral suppression may be lower. We estimated the minimum ART adherence level necessary to achieve viral suppression. SETTINGS: The Patient-centered HIV Care Model demonstration project. METHODS: Adherence to ART was calculated using t…
Changes in Reported Injection Behaviors Following the Public Health Response to an HIV Outbreak Among People Who Inject Drugs
Improvements in Retention in Care and HIV Viral Suppression Among Persons with HIV and Comorbid Mental Health Conditions
The Future of Pharmacist-Delivered Status-Neutral HIV Prevention and Care
The Future of Pharmacist-Delivered Status-Neutral HIV Prevention and Care Paul J. Weidle PharmD, MPH, John T. Brooks MD, Sheila Salvant Valentine JD, and Demetre Daskalakis MD, MPH Affiliation Paul J. Weidle, John T. Brooks, Sheila Salvant-Valentine, and Demetre Daskalakis are with the Division of HIV Prevention, National Center for HIV, Viral Hepatitis, STD & TB Prevention, Centers for Disease Control and Prevention (CDC), Atlanta, GA. Note. The…
Evaluation of Public Health Contact Tracing for Mpox Among Gay, Bisexual, and Other Men Who Have Sex With Men—10 US Jurisdictions, May 17–July 31, 2022
Objectives. To examine the potential impact of contact tracing to identify contacts and prevent mpox transmission among gay, bisexual, and other men who have sex with men (MSM) as the outbreak expanded. Methods. We assessed contact tracing outcomes from 10 US jurisdictions before and after access to the mpox vaccine was expanded from postexposure prophylaxis for persons with known exposure to include persons at high risk for acquisition (May 17–J…
Medicine (10 works) · HIV/AIDS Research and Interventions (9 works) · Family medicine (7 works) · HIV, Drug Use, Sexual Risk (7 works) · Public health (5 works) · Environmental health (4 works) · Human immunodeficiency virus (HIV) (4 works) · Nursing (4 works) · Viral load (4 works) · Virology (4 works)